The regulations have not been changed in over 20 years, despite major changes in the pharmaceutical market. Canadians are now paying some of the highest drug prices in the developed world. This impacts patients and the sustainability of Canada’s health care system.

We are committed to improving the affordability, accessibility and appropriate use of prescription drugs to better meet health care system needs. This important work includes reducing the cost of prescription drugs by updating the patented drug pricing framework.

Who

We are seeking feedback on proposed amendments to the regulations, prior to their pre-publication in Part I of the Canada Gazette, from:

consumer groups

employers

federal drug plans

health professionals

health researchers

pharmaceutical industry

private insurers

provincial and territorial drug plans

other stakeholders

any interested members of the public

What

Health Canada is looking for comments on the following regulatory proposal: